| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 2, 2024 | NLC Health Ventures and BioScience Valuation (BSV) initiate a strategic collaboration | PRESS RELEASE
Amsterdam, February 2nd
NLC Health Ventures and BioScience Valuation (BSV) announce strategic collaboration
NLC Health Ventures and BioScience Valuation (BSV) initiate a strategic collaboration to accelerate venture creatio... |
| Jan 24, 2024 | CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life. | CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life.
We are honored to introduce NLC among our partners!
With the goal to advance health, NLC selects the most promising healthtech inventions and builds them... |
| Dec 21, 2023 | POROUS wins innovation award | December, 2023
POROUS GmbH receives prestigious Berlin Brandenburg Innovation Award 2023 for groundbreaking ultrasound technology in osteoporosis detection. The award recognizes POROUS for its innovative work in making early detection of o... |
| Dec 19, 2023 | Ansana secures a €850,000 investment | Maastricht, December 2023
Ansana’s breakthrough sterilization technology attracts a €850,000 investment to transform patient safety and environmental impact.
Every year, Surgical Site Infection (SSI) affects roughly 3 million patients in ... |
| Dec 5, 2023 | INTRODUCING LIFTYA: STABILITY WITH MOTION | Amsterdam, 05/12/2023
Liftya is a bracing solution that preserves the range of motion, improving the rehabilitation and quality of life of patients with shoulder disorders.
Shoulder instability occurs when the head of the upper arm bone i... |
| Nov 29, 2023 | MLA Diagnostics secures a 7-figure funding round | Maastricht, November 2023
Dutch start-up MLA Diagnostics, on a mission to improve tailored treatments for skin cancer patients, secures funding for continued development towards clinical trials.
Cutaneous melanoma, a cancer that starts in... |
| Nov 27, 2023 | INTRODUCING AXIAL ORTHOPAEDICS INC: A differentiated intramedullary nailing system | November 27, 2023
Axial Orthopaedics Inc. offers a differentiated design of an intramedullary nailing system, targeting the complex surgeries of 1.2 million long bone fracture procedures per annum at a US market revenue spend of over $1 bi... |
| Nov 16, 2023 | Introducing StarTric: Transcatheter tricuspid heart valve repair | Amsterdam, 16/11/2023
StarTric is poised to revolutionize the treatment of tricuspid heart valve regurgitation with the first minimally invasive, transcatheter approach that replicates the Clover surgical technique.
Tricuspid regurgitatio... |
| Nov 13, 2023 | Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions | Amsterdam & Cardiff, 13 November 2023
Led by CEO Iestyn Foster, Amotio is on a mission to transform the way joint implant revision surgery is conducted.
By 2030, an estimated 1.4 billion individuals will be the beneficiaries of hip, k... |
| Nov 10, 2023 | NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted. | November, 2023, Amsterdam.
Sifted, the Financial Times’ platform for innovation and start-ups, named NLC as the most active early-stage healthcare investor in Europe. The list mentions the top 50 early-stage investors, based on DealRoom da... |
| Nov 9, 2023 | CHECK OUT OUR LATEST VENTURE: ChARM
PRESS RELEASE | Amsterdam, 07/11/2023
Every year, roughly 900,000 children around the world under the age of five lose their lives to pneumonia, a preventable and easily treatable disease. This alarming statistic is what drives Maarten Neve, CEO of Ch... |
| Oct 31, 2023 | INTRODUCING OUR NEWEST VENTURE: ASCLEPIUS | 31 October 2023
Asclepius MedTech Ltd. provides a remote patient monitoring platform set to revolutionize pre- and post-operative surgical assessments by unleashing and unlocking the power of data.
In the wake of the COVID-19 pandemic, th... |
| Oct 13, 2023 | NTRODUCING OUR VENTURE NILOCAS | Amsterdam, 09/10/2023
Nilocas Ltd. provides a medical device that is set to revolutionise the detection of Coronary Artery Disease in a variety of care settings using a non-invasive detection system
Coronary Artery Disease is still the le... |
| Oct 11, 2023 | Porous nominated for the Innovation Award Berlin Brandenburg | POROUS GmbH is nominated for the Innovation Award Berlin Brandenburg 2023.
Osteoporosis is a chronic widespread disease that affects hundreds of millions of
people worldwide.
POROUS GmbH has developed an innovative ultrasound method that... |
| Oct 2, 2023 | NLC Announces Crowdfunding Campaign | Amsterdam, 01/10/2023— NLC, the World’s largest Venture Builder, is excited to announce the launch of its crowdfunding campaign on WeFunder. This step is part of a larger €10 million round they are raising, to bring healthcare innovations t... |
| Sep 1, 2023 | TherageniX and University of Nottingham Awarded £995K |
– Novel non-viral gene delivery platform to help advance tissue repair following orthopaedic surgery
– Funding from Innovate UK’s Transforming Medicines Manufacturing programme supporting innovative technologies for intracellular drug de... |
| Jul 20, 2023 | IPD secures funding of €2.1M to initiate its first-in-human trials for prosthetic joint infections | PRESS RELEASE
Amsterdam, July 20, 2023
IPD B.V. (Implant Preservation Devices), a Netherlands-based start-up specializing in the treatment of prosthetic joint infections, raised €2.1 million in its seeding round, which closed on Friday Ju... |
| Jul 19, 2023 | NLC and Australia’s BioCurate announce Strategic Alliance for Commercialization of New Therapies | Amsterdam, July 19, 2023
NLC, the European Healthtech Venture Builder based in the Netherlands, and BioCurate, an independently operated joint venture between The University of Melbourne and Monash University, announced today they have sig... |
| Jun 28, 2023 | NLC sluit eerste ronde van het NLC Health Impact Fund | PERSBERICHT
28 juni 2023
NLC, de grootste Healthtech Venture Builder van Europa, kondigt met trots de sluiting van de eerste investeringsronde van het NLC Health Impact Fund aan.
Het NLC Health Impact Fund is het nieuwste en grootste fon... |
| Jun 27, 2023 | IN THE NEWS: HEALTH IMPACT FUND INITIAL CLOSE | Following the successful initial close of our flagship NLC Health Impact Fund, NLC is proudly featured in the news. Business and financial news outlets stress the significance of the funds raised from private investors against the current t... |
| Jun 26, 2023 | NLC announces it has completed the initial close of the NLC Health Impact Fund |
June 26, 2023
40 high-impact ventures will receive investments from the largest European healthtech venture builder following the successful initial close of its flagship NLC Health Impact Fund.
The NLC Health Impact Fund is the latest ... |
| Jun 23, 2023 | INTRODUCING OCCLUNOVA: AN IMPLANTABLE DEVICE FOR CHRONIC ATRIAL FIBRILLATION (AF) | June 23, 2023
Atrial fibrillation (AF) affects 4.5 million people in Europe and more than 3 million in the US. It has seen a 33% rise over the last 20 years and almost 12 million people in the US alone are predicted to develop AF by 2030. ... |
| Jun 12, 2023 | INTRODUCING THERAGENIX: GENE-BASED TISSUE REGENERATION | June 12, 2023
Disease, injuries and aging can damage body tissues. There is an unmet need for novel therapies to enable tissue repair and regeneration. The use of gene therapy to provide biological cues to boost the body’s response has bee... |
| Mar 20, 2023 | INTRODUCING PROVASCTEC : A CELL THERAPY FOR PATIENTS WITH CRITICAL LIMB ISCHEMIA | March 20, 2023
Atherosclerosis describes the build-up of fats, cholesterol and other substances within the inner arterial walls. This build-up, also called plaque, can cause arteries to narrow and eventually completely block the arterial b... |
| Mar 6, 2023 | INTRODUCING HEAT2MOVE: A NON-MEDICAL AND NON-INVASIVE PAIN RELIEVING TECHNOLOGY | March 6, 2023
About 20% of the world’s population is affected by various degrees of chronic back pain. The total market for back pain treatment is estimated at over €50 billion with current treatment options mainly consisting of medication... |
| Feb 28, 2023 | INTRODUCING ANSANA: A NEW STERILIZATION TECHNOLOGY FOR THE HEALTHCARE & PHARMACEUTICAL INDUSTRY. | February 28, 2023
Across the globe, Healthcare-Associated Infections (HAI) range from 5% to 12% due to surgical instrument reprocessing. In the US and Europe alone, 6 million patients are affected yearly with HAIs resulting in an annual ... |
| Feb 27, 2023 | INTRODUCING CAREBED: A MOBILE-FRIENDLY SOLUTION FOR THE ELDERLY | February 27, 2023
Being dependent on another person to do this has a strong effect on your well being and self esteem. Some 20% rising up to 60% of the elderly have trouble getting in and out of bed. Currently, patient transfers are effect... |
| Feb 23, 2023 | SERDA therapeutics submits IND | |
| Feb 15, 2023 | MINDAFFECT AWARDED EUROSTARS GRANT | February 15, 2023
With approximately 175 million disabled adults in Europe and the US, the system will fill a very important diagnostic and screening system gap in the market. Today’s systems require a consistent patient response – which i... |
| Feb 15, 2023 | NC BIOMATRIX WINS EIC GRANT | February, 15 2023
Hundreds of millions of people worldwide suffer from chronic back pain. According to the WHO, it remains one of the leading causes of disability and lost economic value. The most common cause of persistent back pain is de... |
| Jan 30, 2023 | NLC LAUNCHES FIRST IMPACT REPORT | January 30, 2023
Regardless of their importance or creativity, 95% of all healthtech innovations never make it to market. With increasing demands on healthcare, rising expenses, and a growing lack of health personnel, the world’s healthcar... |
| Nov 8, 2022 | INTRODUCING CONCORD BIRTH FLOW: BUILDING THE FUTURE OF CHILD BIRTH | November 8, 2022
St. Antonius Hospital is the first hospital with level 2 neonatal care worldwide using the newborn care table.
Developed over 7 years ago at the Leiden University Medical Center (LUMC) and based on the work of paediatrici... |
| Oct 11, 2022 | MINDAFFECT SELECTED FOR POLE POSITION PROGRAMME | October 11, 2022
MindAffect, a BCI/AI Healthtech company specializing in the development of NextGen hearing/vision diagnostic systems, is delighted to have been selected for the Pole Position Programme – a new, exclusive initiative aimed a... |
| Oct 5, 2022 | INTRODUCING CRAINIO: REVOLUTIONISING THE MEASUREMENT OF INTRACRANIAL PRESSURE | October 5, 2022
In situations where our brain experiences a force of impact, for example, falling and hitting your head or being in a car accident, our brain sustains trauma. ICP is the build-up of pressure in the brain due to trauma, and ... |
| Sep 27, 2022 | INTRODUCING BIODGRAFT: A SOLUTION FOR LIFE | September 27, 2022
Cardiovascular disease causes 1 in every 4 deaths, making it the leading cause of death worldwide (1).
Coronary artery disease (CAD) is a type of cardiovascular disease in which the coronary arteries are narrowed due to... |
| Sep 8, 2022 | INTRODUCING AIDO: BUILDING THE FUTURE PLATFORM FOR INTERVENTIONAL ENDOSCOPY | September 8, 2022
A physician may routinely perform 5 to 10 endoscopic procedures every day. The procedure involves the insertion of the endoscope, a long, flexible tube, down the patient’s throat, into the oesophagus. A small camera at th... |
| Aug 22, 2022 | NLC Collaborates with FFUND and ttopstart to accelerate growth of healthtech ventures | PRESS RELEASE
AUGUST 22, 2022
NLC – The European Healthtech Venture Builder, FFUND and ttopstart partner to accelerate the growth of life-saving healthcare ventures
NLC searches the globe for the most promising healthtech innovations and... |
| Aug 2, 2022 | Haermonics Series A funding offers Pure™ promise for future heart surgery patients | Eindhoven, the Netherlands, August 2, 2022
Haermonics, a clinical-stage breakthrough medtech company, has successfully closed a 4.3 M Series-A financing round with an investment syndicate led by existing shareholder BOM, strategic partner ... |
| Jul 18, 2022 | Introducing AETHERUS: offering rapid relief to those suffering from breathlessness | July 15, 2022
COPD is a progressive and irreversible lung disease, afflicting approximately 384 million individuals worldwide (~5% of the population). The most debilitating symptom of COPD is breathlessness, which impairs the patients’ abi... |
| Jun 14, 2022 | Bright times ahead for SuperSeton | PRESS RELEASE
May 2022
For the second year in a row, SuperSeton has been selected as one of 29 initiatives to join
the EITHealth BridgeHead Global programme. This initiative was established to help bring
the best of European healthcare ... |
| May 23, 2022 | Allergios closes their latest round of seed financing | Allergios – a biomedical start-up with an innovative allergy test that produces unprecedented accurate results – has just closed their latest round of seed financing. Oversubscribed, this financial contribution will enable them to take thei... |
| Apr 26, 2022 | Investment in ARNE helps neonatologists treat newborn babies | PRESS RELEASE
April 26, 2022
ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists can make decisions based on data after the birth of a child. This reduces the number ... |
| Apr 20, 2022 | Charles River Laboratories and NLC Collaborate | PRESS RELEASE
April 2022
NLC – The European Healthtech Venture Builder and Charles River Laboratories team up to drive drug discovery projects towards finding innovative therapeutics.
Charles River Laboratories (“Charles River”) and NLC-... |
| Mar 14, 2022 | Scinvivo secures 1 Million investment for in human clinical trials & CE | Press Release
Eindhoven, March 10th, 2022
Scinvivo 1 million investment secured towards in human clinical trials & CE for game-changing cancer diagnostics
Scinvivo, a MedTech startup based in Eindhoven, has closed an investment rou... |
| Feb 25, 2022 | Hemeo raises €675,000 in an oversubscribed seed equity round | Hemeo announces the successful closure of its first equity finance round. Raising €675,000, it has been substantially oversubscribed, highlighting the strong interest raised by the potential of the Hemeo technology designed to revolutionise... |
| Jan 24, 2022 | Bilihome successfully closes an investment round for smart, wearable light therapy for newborns with jaundice | PRESS RELEASE
Bilihome successfully closes an investment round for smart, wearable light therapy for newborns with jaundice
Margret Huenerbein, [email protected], www.bilihome.org
Nijkerk, the Netherlands Monday 24 January 2022 –... |
| Jan 20, 2022 | IPD secures funding of €1.5 million to develop its first-in-human prototype for prosthetic joint infections | IPD bv (Implant Preservation Devices), a Dutch-based startup specialising in the treatment of prosthetic joint infections, raised €1.5 million of dilutive and non-dilutive financing in 2021, contributing to the development of its first-in-h... |
| Apr 22, 2021 | SuperSeton – because life is more convenient without knots | News:
Despite COVID measures across Europe, heavily affecting fistula treatmen through postponement or cancellation, SuperSeton had its best quarter ever. Our expanding network of quality distributors across Europe and beyond (see Distribu... |
| Apr 22, 2021 | Concord generated its first sales in Germany | News:
Concord generated its first sales in Germany. The University Hospital Dresden became the first hospital in Germany to perform the Concord Birth Flow.
On March 19 the little girl Maira was born in the 34th week of pregnancy with a we... |
| Apr 22, 2021 | Aetherus | News:
Aetherus signed a contract with an American partner that will be responsible for FDA approval and marketing & sales in North America. The team is ongoing discussions with NOM for an investment, and with UMC Groningen for performi... |
| Apr 22, 2021 | NLC successfully closes €20 million equity financing round to further strengthen and scale its venture building model | Amsterdam, Friday 23 April 2021 – NLC is proud to announce that its latest funding round is successfully closed. Investments come from family offices across Europe, underlining NLC’s ambitions to become a true PAN European player.
NLC’s CE... |
| Apr 22, 2021 | PoroUS securing a first round investment | News:
In cooperation with the Charité University in Berlin, PoroUS has made big progress executing it’s strategy to ultimately avoid osteoporosis in patients by diagnosing the early phase of increasing bone porosity. Bart Hendriks has been... |
| Apr 22, 2021 | OsteoWeld received grant from Innovate UK | News:
OsteoWeld received a GBP500k grant from Innovate UK. The submission was prepared together with the University of Birmingham, which will collaborate with OsteoWeld to bring its exciting orthopaedic technology to market.
The grant wil... |
| Apr 22, 2021 | Artifex | News:
In a joint effort with the University Hospital in Basel and the Medical University in Vienna, ArtiFex secured €350k in their first funding round and is ready to start animal trials.
The ArtiFex vascular graft aims to provide a much ... |
| Apr 21, 2021 | NICO.LAB reaches major milestone | News:
One of the first ventures NLC built (in 2015) has grown wings to fly. Recently NICO.LAB announced a major milestone: the closing of a whopping A$13M (€8.4M) pre-IPO round!
After 5 years of tireless work, moving forward on that typic... |
| Apr 14, 2021 | Next generation financing instruments for early stage biotech ventures in Europe | Friday April 16th, 10:30 – 11:00, live from the studio at the Innovation for Health event, Koen Verhoef, Head of Knowledge Transfer & Contracting at Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, and our founder and CEO... |
| Mar 25, 2021 | Press Release: NLC closes second funding round of Stepping Stone Fund to finance 40 new promising HealthTech ventures | Amsterdam, Thursday 25 March 2021 – We are very pleased to announce that we’ve closed the second funding round of our Stepping Stone Fund. With the Stepping Stone Fund, NLC will invest in 40 early-stage, high-impact HealthTech ventures. NLC... |
| Mar 8, 2021 | A lot to celebrate at PEP Health with Meghan Leaver | Recently there’s been a lot to celebrate at PEP Health. The Department of International Trade listed PEP on its ’25 to watch’ list and PEP was accepted into the London & Partners Mayor’s International Business Programme, which helps Lon... |
| Feb 18, 2021 | Five recommendations for optimal venture growth in your first six months! | With innovation becoming more and more important in today’s business world; the amount of aspiring entrepreneurs is growing and growing. We at NLC – The European Healthcare Venture Builder have seen more than 60 healthtech and pharma ventur... |
| Jan 29, 2021 | Pressrelease: Concord Neonatal to expand sales internationally | Concord Neonatal, one of the ventures in NLC portfolio, has closed a new funding round, securing substantial funding with private investors. Concord Neonatal is improving birth, by offering solutions to give baby’s a shock-free birth. This ... |
| Jan 18, 2021 | Pressrelease: Intelligent ultrasound technique for diagnosing prostate cancer | Tilburg – 18 january 2021 – CbusineZ, the venture capital investor liaised to health insurer CZ, will together with a group of private investors, invest in the startup Angiogenesis Analytics. Angiogenesis Analytics has developed a method to... |
| Jan 8, 2021 | NLC concludes Framework Agreement with patent attorny firm De Vries & Metman | NLC has concluded a Framework Agreement with Amsterdam based patent attorney firm De Vries & Metman for their patent and IP protection services.
“The best IP should be protected in the best possible way”, says Michiel Mussies, Lead Ven... |
| Dec 17, 2020 | Inventor Brochure | Read the Inventor Brochure |
| Dec 17, 2020 | NLC’s current venture portfolio | NLC’s current venture portfolio |
| Dec 15, 2020 | NLC successfully closes the new Stepping Stone Fund to finance 40 promising new HealthTech ventures | Amsterdam, Tuesday 15 December 2020 – Today, NLC closed the first round of the new NLC Stepping Stone Fund. NLC – the European HealthTech Venture Builder – was founded in 2015 based on the urgency that due to market complexities and fragmen... |
| Dec 8, 2020 | Rob ten Hoedt joins Supervisory Board | We are pleased to announce that Rob ten Hoedt has agreed to join NLC’s Supervisory Board per December 1st 2020. Rob is Executive Vice President and President EMEA at Medtronic, and Chair and Member of the Operations Management Committee of ... |
| Nov 30, 2020 | Bridging The Valley: | |
| Oct 15, 2020 | NLC and Medtech Europe publish reflection paper on how to improve the innovative landscape of Europe in health tech | MedTech Europe in collaboration with NLC published a reflection paper outlining how Europe can provide a more attractive landscape for Innovation in health tech. The paper is a first in its kind and provides extensive data on the R&I re... |
| Oct 14, 2020 | Unleash the potential of healthtech innovation. Together. | Ever since the Covid-19 crisis started, NLC has adopted the strategy “prepare for the worst, prepare for the best”. Now, six months later, we are focussing on the latter. Every month, we create new, life impacting ventures. Our existing por... |
| Oct 5, 2020 | 4 NLC Ventures shortlisted for 2020 Academic Startup Competition | Out of a total of 20 ventures that have been shortlisted for the 2020 Academic Startup Competition, no less than 4 are ventures from NLC’s portfolio.
NCBiomatrix, Kaminari Medical, MLA Diagnostics and Venous Stent have all been selected to... |
| Jun 30, 2020 | NLC formally founded and registered the new NLC Stepping Stone Fund | NLC – The European Healthtech Venture Builder formally founded and registered the new NLC Stepping Stone Fund. This means that the ‘marketing phase’ of the new fund has now commenced, and we are currently welcoming the first investors to jo... |
| Jun 25, 2020 | How healthtech innovations arise during the COVID-19 crisis | At the start of the COVID-19 outbreak in Europe, NLC developed a website for people to share COVID-19 related ideas and innovations. With over 140 uploaded to the site, we wanted to share the insights we gained from these contributions.
In... |
| Jun 17, 2020 | NLC and MD squared conclude Framework Agreement for Venture Support | Amsterdam/Eindhoven
NLC – the European HealthTech Venture Builder, has concluded a Framework Agreement with the Eindhoven based MD squared, a Medical Consultancy for Medical Devices, on offering project support for its ventures during thei... |
| Jun 2, 2020 | Do’s and don’ts when filing a patent | One of the most important, yet also most daunting and complicated tasks in the process of bringing an invention to the market, is securing the appropriate patent. The process can take up a lot of time and resources, and failing to secure a ... |
| May 20, 2020 | NLC obtains the B Corp certificate: business as a force for good | NLC is extremely proud to announce that as of March 2020, it became a Certified B Corporation. That means that the non-profit B Lab established that it meets their rigorous standards of social and environmental performance, accountability, ... |
| Mar 28, 2020 | Corona pandemic – the call for healthtech entrepreneurship | |
| Mar 7, 2020 | Let’s embrace our European fragmentation and work together to fight corona | Europe has all the ingredients to develop a vaccine for COVID-19. Read about the health innovation ecosystem of Europe and what we can do together to improve the health of every citizen in the world.
Probably many of you read or heard abou... |
| Sep 5, 2019 | Concord Neonatal achieves CE mark for the Concord Birth Trolley | |
| Jul 3, 2019 | Concord Neonatal just launched a great animation video explaining why we are so passionate about Concord | |
| Jun 12, 2019 | Interview Bert Arjan Millenaar with Paul van Liempt | Interview (in Dutch but subtitled in English) with Paul van Liempt, explaining the NLC – The Healthtech Venture Builder way of bringing science to life.
|
